Another Drug Expected to Fail Trials

Another drug targeted to SLE is unlikely to make it beyond late stage testing. Results will be released on Monday, July 20th, but the data for Human Genome Sciences Benlysta little chance of ever reaching the market. The goal of the drug is improvement and stabilization of SLE and reducing the frequency of flares.

Read the full article on Reuters.com

Leave a comment



About

This time, it IS lupus

Archives


 

Recent Entries